Yukiguni Maitake Company Overview
- Founded
-
1983
- Status
-
Public
- Employees
-
2,291
- Stock Symbol
-
1375
- Investments
-
1
- Share Price
-
$7.78
- (As of Monday Closing)
Yukiguni Maitake Company General Information
Description
Yukiguni Maitake Co Ltd is engaged in the production and sale of maitake mushrooms. The firm is also involved in the manufacturing and selling of processed mushroom foods. Its products are Yukiguni Eringi, Premium Tamba-Shimeji, Premium Daikoku Hon-Shimeji, Eringi Rice Mix, Health Foods, and others.
Contact Information
Primary Industry
Food Products
Other Industries
Horticulture
Stock Exchange
TKS
Primary Office
- 89 Yokawa, Minamiuonuma-shi
- Niigata, 949-6695
- Japan
+81 000-000-0000
Yukiguni Maitake Company Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $7.78 | $7.78 | $6.25 - $9.88 | $310M | 39.9M | 53.9K | $0.25 |
Yukiguni Maitake Company Financials Summary
|
In Thousands, USD |
TTM 31-Dec-2022 | FY 2022 31-Mar-2022 | FY 2021 31-Mar-2021 | FY 2020 31-Mar-2020 |
|---|---|---|---|---|
| EV | 435,561 | 513,673 | 885,672 | |
| Revenue | 327,785 | 419,073 | 484,536 | 466,825 |
| EBITDA | 34,204 | 61,944 | 92,437 | 77,842 |
| Net Income | 10,158 | 26,606 | 44,738 | 39,970 |
| Total Assets | 283,008 | 295,753 | 323,109 | 325,696 |
| Total Debt | 147,331 | 156,070 | 181,733 | 222,618 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Yukiguni Maitake Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Yukiguni Maitake Company Patents
Yukiguni Maitake Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2020002052-A | Therapeutic and/or prophylactic agent for norovirus infection | Pending | 28-Jun-2018 | ||
| JP-2019172597-A | Therapeutic and/or preventive agent for herpes infection | Pending | 27-Mar-2018 | ||
| JP-2018070497-A | Composition for treatment and/or prevention of herpes infection using grifola frondosa extract | Pending | 28-Oct-2016 | ||
| JP-2014080373-A | Herpes simplex virus infection preventive/therapeutic agent from grifola frondosa extract | Active | 12-Oct-2012 | ||
| JP-6080479-B2 | Preventive and therapeutic agent for herpes simplex virus infection derived from maitake extract | Active | 12-Oct-2012 |
Yukiguni Maitake Company Executive Team (7)
Yukiguni Maitake Company Board Members (15)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000000 000000 | Yukiguni Maitake Company | Chairman & President | 000 0000 |
| 00000000 000000 | Yukiguni Maitake Company | Board Member | 000 0000 |
| 00000 000000 | Self | Board Member | 000 0000 |
| 000000 00000 | Bain Capital | Board Member | 000 0000 |
| 000000 00000 | Yukiguni Maitake Company | Board Member | 000 0000 |
Yukiguni Maitake Company Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Yukiguni Maitake Company Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Yukiguni Maitake Company Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 00000 | 13-Oct-2010 | 00000 0000 | 00000 | Cultivation |
Yukiguni Maitake Company ESG
Risk Overview
Risk Rating
Updated April, 01, 2022
50.13 | Severe Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.0
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 14,912
Rank
00.00
Percentile
Food Products
Industry
00 of 591
Rank
00.00
Percentile
Agriculture
Subindustry
00 of 95
Rank
00.00
Percentile
